{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T20:35:13Z","timestamp":1779136513369,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.clgc.2014.06.005","type":"journal-article","created":{"date-parts":[[2014,6,7]],"date-time":"2014-06-07T21:16:06Z","timestamp":1402175766000},"page":"44-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Neoadjuvant Taxane-Based Combination Chemotherapy in Patients With Advanced Penile Cancer"],"prefix":"10.1016","volume":"13","author":[{"given":"Rosa S.","family":"Djajadiningrat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andries M.","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"van Werkhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Vegt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Horenblas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2014.06.005_bib1","first-page":"359","article-title":"Advanced penile carcinoma","volume":"170","author":"Culkin","year":"2003","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2014.06.005_bib2","first-page":"1335","article-title":"Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma","volume":"177","author":"Bermejo","year":"2007","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2014.06.005_bib3","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.eururo.2007.02.006","article-title":"Neoadjuvant chemotherapy in advanced penile carcinoma","volume":"52","author":"Leijte","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2014.06.005_bib4","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","article-title":"Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer","volume":"357","author":"Vermorken","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clgc.2014.06.005_bib5","doi-asserted-by":"crossref","first-page":"8636","DOI":"10.1200\/JCO.2004.00.1990","article-title":"Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer","volume":"23","author":"Hitt","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2014.06.005_bib6","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.urology.2003.12.026","article-title":"Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer","volume":"63","author":"Joerger","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2014.06.005_bib7","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.eururo.2008.07.014","article-title":"Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results","volume":"55","author":"Pizzocaro","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2014.06.005_bib8","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","article-title":"Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study","volume":"28","author":"Pagliaro","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2014.06.005_bib9","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.eururo.2011.08.028","article-title":"Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study","volume":"60","author":"Di Lorenzo","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2014.06.005_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/CAD.0b013e328329a293","article-title":"Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients","volume":"20","author":"Di Lorenzo","year":"2009","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.clgc.2014.06.005_bib11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clgc.2014.06.005_bib12","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.eururo.2010.01.039","article-title":"EAU penile cancer guidelines 2009","volume":"57","author":"Pizzocaro","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2014.06.005_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New Response Evaluation Criteria in Solid Tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clgc.2014.06.005_bib14","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1007\/s00259-010-1434-0","article-title":"18F-FDG PET\/CT for monitoring induction chemotherapy in patients with primary inoperable penile carcinoma: first clinical results","volume":"37","author":"Graafland","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.clgc.2014.06.005_bib15","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0959-8049(99)00229-4","article-title":"Measurement of Clinical and Subclinical Tumour Response Using [18F]-fluorodeoxyglucose and Positron Emission Tomography: Review and 1999 European Organisation for Research and Treatment of Cancer Recommendations","volume":"35","author":"Young","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clgc.2014.06.005_bib16","unstructured":"National Cancer Institute. Common Toxicity Criteria of Adverse Events (CTCAE) V4.0. 2009:http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf."},{"key":"10.1016\/j.clgc.2014.06.005_bib17","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3109\/02841868809094366","article-title":"Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis","volume":"27","author":"Pizzocaro","year":"1988","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clgc.2014.06.005_bib18","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/annonc\/mdn149","article-title":"A\u00a0phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)","volume":"19","author":"Theodore","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clgc.2014.06.005_bib19","first-page":"1124","article-title":"Neoadjuvant cisplatin and interferon-alpha 2B in the treatment and organ preservation of penile carcinoma","volume":"152","author":"Mitropoulos","year":"1994","journal-title":"J\u00a0Urol"},{"issue":"suppl 4","key":"10.1016\/j.clgc.2014.06.005_bib20","article-title":"Survival analysis of adjuvant or neoadjuvant combination of a taxane plus cisplatin and 5-fluoracil (TPF) in patients with bulky nodal metastases from squamous cell carcinoma of the penis (PSCC): results of a single high-volume center","volume":"32","author":"Giannatempo","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2014.06.005_bib21","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1038\/bjc.2013.620","article-title":"Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK\/09\/001)","volume":"109","author":"Nicholson","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clgc.2014.06.005_bib22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/1097-0347(200010)22:7<687::AID-HED8>3.0.CO;2-W","article-title":"Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients","volume":"22","author":"Robbins","year":"2000","journal-title":"Head Neck"},{"key":"10.1016\/j.clgc.2014.06.005_bib23","first-page":"469","article-title":"RADPLAT: an alternative to Surgery?","volume":"11","author":"Alkureishi","year":"2006","journal-title":"Head Neck Cancer"},{"key":"10.1016\/j.clgc.2014.06.005_bib24","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1200\/JCO.2013.49.5283","article-title":"Challenges of guarantee-time bias","volume":"31","author":"Giobbie-Hurder","year":"2013","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767314001062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767314001062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:23:47Z","timestamp":1761564227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767314001062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1558767314001062"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2014.06.005","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant Taxane-Based Combination Chemotherapy in Patients With Advanced Penile Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2014.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}